Literature DB >> 22264384

Preclinical cognitive trajectories differ for Alzheimer's disease and vascular dementia.

Erika J Laukka1, Stuart W S Macdonald, Laura Fratiglioni, Lars Bäckman.   

Abstract

We investigated differences between Alzheimer's disease (AD) and vascular dementia (VaD) from the appearance of the first cognitive symptoms, focusing on both time of onset and rate of accelerated decline for different cognitive functions before dementia diagnosis. Data from a longitudinal population-based study were used, including 914 participants (mean age = 82.0 years, SD = 5.0) tested with a cognitive battery (word recall and recognition, Block Design, category fluency, clock reading) on up to four occasions spanning 10 years. We fit a series of linear mixed effects models with a change point to the cognitive data, contrasting each dementia group to a control group. Significant age-related decline was observed for all five cognitive tasks. Relative to time of diagnosis, the preclinical AD persons deviated from the normal aging curve earlier (up to 9 years) compared to the preclinical VaD persons (up to 6 years). However, once the preclinical VaD persons started to decline, they deteriorated at a faster rate than the preclinical AD persons. The results have important implications for identifying the two dementia disorders at an early stage and for selecting cognitive tasks to evaluate treatment effects for persons at risk of developing AD and VaD.

Entities:  

Mesh:

Year:  2012        PMID: 22264384     DOI: 10.1017/S1355617711001718

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  7 in total

1.  When does cognitive decline begin? A systematic review of change point studies on accelerated decline in cognitive and neurological outcomes preceding mild cognitive impairment, dementia, and death.

Authors:  Justin E Karr; Raquel B Graham; Scott M Hofer; Graciela Muniz-Terrera
Journal:  Psychol Aging       Date:  2018-03

2.  Effect of common neuropathologies on progression of late life cognitive impairment.

Authors:  Lei Yu; Patricia A Boyle; Sue Leurgans; Julie A Schneider; Richard J Kryscio; Robert S Wilson; David A Bennett
Journal:  Neurobiol Aging       Date:  2015-04-22       Impact factor: 4.673

Review 3.  Sex differences in cognitive impairment in Alzheimer's disease.

Authors:  Keith R Laws; Karen Irvine; Tim M Gale
Journal:  World J Psychiatry       Date:  2016-03-22

4.  Profiles of Cognitive Change in Preclinical and Prodromal Alzheimer's Disease Using Change-Point Analysis.

Authors:  Owen A Williams; Yang An; Nicole M Armstrong; Melissa Kitner-Triolo; Luigi Ferrucci; Susan M Resnick
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

5.  Free Recall Episodic Memory Performance Predicts Dementia Ten Years prior to Clinical Diagnosis: Findings from the Betula Longitudinal Study.

Authors:  Carl-Johan Boraxbekk; Anders Lundquist; Annelie Nordin; Lars Nyberg; Lars-Göran Nilsson; Rolf Adolfsson
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2015-05-01

6.  Glutathione Peroxidase Activity Is Altered in Vascular Cognitive Impairment-No Dementia and Is a Potential Marker for Verbal Memory Performance.

Authors:  Mehnaz Ahmed; Nathan Herrmann; Jinghan Jenny Chen; Mahwesh Saleem; Paul I Oh; Ana C Andreazza; Alexander Kiss; Krista L Lanctôt
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

Review 7.  Healthy Aging and Dementia: Two Roads Diverging in Midlife?

Authors:  Katie Irwin; Claire Sexton; Tarun Daniel; Brian Lawlor; Lorina Naci
Journal:  Front Aging Neurosci       Date:  2018-09-19       Impact factor: 5.750

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.